| Authors: |
van der Plas-van Duijn A; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, the Netherlands., Winkelman LMT; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Lensen C; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., van Duivendijk M; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Derksen I; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., van Veenendaal JMF; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., Schaap G; Department of Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, the Netherlands., Sluijter M; Department of Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, the Netherlands., van Groningen TJB; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands., van Hall T; Department of Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, the Netherlands., Slieker RC; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Medical Oncology, Oncode institute, Leiden University Medical Center, Leiden, the Netherlands., Sharp TH; School of Biochemistry, University of Bristol, Bristol, United Kingdom., Beltman JB; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Bresser K; T Cell Differentiation Lab, Department of Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands., Scheeren FA; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands. f.a.scheeren@lumc.nl. |
